BioCurex, Inc.(fka BOCX)

[lighthouse]

"The derailing of the GE purchase of Abbott Diagnostics and more importantly, the advent of an economic recession of this proportion was obviously not predictable. These facts, together with the very positive development of ELISA-RECAF tests that can be done in any clinical lab anywhere in the world; has changed our strategy: We are now devoting practically all of our resources to commercializing the RECAF blood tests as described below."


Now that is interesting... curious what you readers are thinking about this.